A comprehensive review of challenges and opportunities for stem cell research in India.

Q2 Medicine Perspectives in Clinical Research Pub Date : 2025-01-01 Epub Date: 2024-08-30 DOI:10.4103/picr.picr_273_23

Kavita Srivastava, Lily Srivastava, Tanvi Jain

{"title":"A comprehensive review of challenges and opportunities for stem cell research in India.","authors":"Kavita Srivastava, Lily Srivastava, Tanvi Jain","doi":"10.4103/picr.picr_273_23","DOIUrl":null,"url":null,"abstract":"<p><p>Stem cell research is a major focus for scientific and medical communities worldwide due to the potential for stem cells to restore function lost due to disease, trauma, congenital abnormalities, and aging. Stem cells can repair, replace, or regenerate damaged cells, tissues, or organs, making them an important area of research in regenerative medicine. India is emerging as a prominent hub for the development of stem cell therapy (SCT), and it is important to assess the current state of stem cell research in India and the potential for advancement to promote stem cell-based therapy. However, several barriers exist in India that are hindering the rapid expansion of SCT. This article examines the existing regulations that govern SCT in India, comparing them with regulations in developed nations, particularly for patients with unmet clinical needs. It also highlights the importance of public education in dispelling myths, addressing concerns, and promoting the benefits of stem cell research. The article concludes with recommendations for enhancing safety measures in SCT applications to ensure ethical practices and patient well-being.</p>","PeriodicalId":20015,"journal":{"name":"Perspectives in Clinical Research","volume":"16 1","pages":"3-8"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11759228/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Perspectives in Clinical Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/picr.picr_273_23","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/8/30 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

Abstract

Stem cell research is a major focus for scientific and medical communities worldwide due to the potential for stem cells to restore function lost due to disease, trauma, congenital abnormalities, and aging. Stem cells can repair, replace, or regenerate damaged cells, tissues, or organs, making them an important area of research in regenerative medicine. India is emerging as a prominent hub for the development of stem cell therapy (SCT), and it is important to assess the current state of stem cell research in India and the potential for advancement to promote stem cell-based therapy. However, several barriers exist in India that are hindering the rapid expansion of SCT. This article examines the existing regulations that govern SCT in India, comparing them with regulations in developed nations, particularly for patients with unmet clinical needs. It also highlights the importance of public education in dispelling myths, addressing concerns, and promoting the benefits of stem cell research. The article concludes with recommendations for enhancing safety measures in SCT applications to ensure ethical practices and patient well-being.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

干细胞研究是全球科学界和医学界关注的焦点，因为干细胞具有恢复因疾病、创伤、先天畸形和衰老而丧失的功能的潜力。干细胞可以修复、替代或再生受损的细胞、组织或器官，因此成为再生医学的重要研究领域。印度正在成为发展干细胞疗法（SCT）的一个重要中心，因此，评估印度干细胞研究的现状和发展潜力，以促进基于干细胞的疗法，是非常重要的。然而，印度存在一些障碍，阻碍了干细胞治疗的快速发展。本文探讨了印度现有的干细胞移植法规，并与发达国家的法规进行了比较，尤其是针对临床需求未得到满足的患者。文章还强调了公众教育在消除误解、消除顾虑和宣传干细胞研究益处方面的重要性。文章最后建议加强干细胞移植应用中的安全措施，以确保道德实践和患者福祉。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Perspectives in Clinical Research Medicine-Medicine (all)

CiteScore

2.90

自引率

0.00%

发文量

审稿时长

36 weeks

期刊介绍： This peer review quarterly journal is positioned to build a learning clinical research community in India. This scientific journal will have a broad coverage of topics across clinical research disciplines including clinical research methodology, research ethics, clinical data management, training, data management, biostatistics, regulatory and will include original articles, reviews, news and views, perspectives, and other interesting sections. PICR will offer all clinical research stakeholders in India – academicians, ethics committees, regulators, and industry professionals -a forum for exchange of ideas, information and opinions.